Literature DB >> 12438439

Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

William Y Ho1, Cassian Yee, Philip D Greenberg.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12438439      PMCID： PMC151827          DOI： 10.1172/JCI17214

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  27 in total

1.  Il-12 enhances CD8 T cell homeostatic expansion.

Authors:  W C Kieper; M Prlic; C S Schmidt; M F Mescher; S C Jameson
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

2.  Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Ryotaro Ishimitsu; Taketo Watase; Dirk H Busch; Eric G Pamer; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 3.  Interleukin-12 in anti-tumor immunity and immunotherapy.

Authors:  Mario P Colombo; Giorgio Trinchieri
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

4.  Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

Authors:  Marcela V Maus; Anna K Thomas; Debra G B Leonard; David Allman; Kathakali Addya; Katia Schlienger; James L Riley; Carl H June
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

5.  CD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.

Authors:  R M Kedl; M Jordan; T Potter; J Kappler; P Marrack; S Dow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

6.  Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells.

Authors:  Lukas Hunziker; Paul Klenerman; Rolf M Zinkernagel; Stephan Ehl
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

7.  Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death.

Authors:  Laurence E Cheng; Claes Ohlén; Brad H Nelson; Philip D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

8.  T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Authors:  Wolfgang Dummer; Andreas G Niethammer; Roberto Baccala; Brian R Lawson; Norbert Wagner; Ralph A Reisfeld; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

Authors:  S J Brodie; D A Lewinsohn; B K Patterson; D Jiyamapa; J Krieger; L Corey; P D Greenberg; S R Riddell
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

10.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307
View more
  33 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy.

Authors:  M Montes; N Rufer; V Appay; S Reynard; M J Pittet; D E Speiser; P Guillaume; J-C Cerottini; P Romero; S Leyvraz
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.

Authors:  Ralf-Holger Voss; Jürgen Kuball; Renate Engel; Philippe Guillaume; Pedro Romero; Christoph Huber; Matthias Theobald
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy.

Authors:  Matthias Wölfl; Katharina Merker; Henner Morbach; Stefaan W Van Gool; Matthias Eyrich; Philip D Greenberg; Paul G Schlegel
Journal:  Cancer Immunol Immunother       Date:  2010-10-24       Impact factor: 6.968

5.  Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.

Authors:  Maciej Kmieciak; Debasmita Basu; Kyle K Payne; Amir Toor; Adly Yacoub; Xiang-Yang Wang; Lisa Smith; Harry D Bear; Masoud H Manjili
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

6.  Establishment of tumor-associated immunity requires interaction of heat shock proteins with CD91.

Authors:  Yu Jerry Zhou; Michelle Nicole Messmer; Robert Julian Binder
Journal:  Cancer Immunol Res       Date:  2013-12-31       Impact factor: 11.151

7.  CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.

Authors:  Roman Puliaev; Irina Puliaeva; Lisbeth A Welniak; Abigail E Ryan; Mark Haas; William J Murphy; Charles S Via
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

Authors:  Ying Xie; Akgül Akpinarli; Charles Maris; Edward L Hipkiss; Malcolm Lane; Eun-Kyung M Kwon; Pawel Muranski; Nicholas P Restifo; Paul Andrew Antony
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

Review 9.  Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.

Authors:  Yolanda Nesbeth; Jose R Conejo-Garcia
Journal:  Clin Dev Immunol       Date:  2010-11-07

Review 10.  Immunotherapy of cancer: from vision to standard clinical practice.

Authors:  Christoph H Huber; Thomas Wölfel
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.